Dermaseptin 01 as antimicrobial peptide with rich biotechnological potential: Study of peptide interaction with membranes containing Leishmania amazonensis lipid-rich extract and membrane models

Journal of Peptide Science

Volumn 17, Issue 10, 2011, Pages 700-707

  Salay, Luiz C ^a,e   Nobre, Thatyane M ^a   Colhone, Marcelle C ^a   Zaniquelli, Maria E D ^a   Ciancaglini, Pietro ^a   Stabeli, Rodrigo G ^b,c   Leite, José Roberto S A ^d   Zucolotto, Valtencir ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE FEDERAL DE RONDÔNIA   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^e DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

Author keywords

Antimicrobial peptides; Dermaseptin 01; Dilatational surface elasticity; Leishmania amazonensis; Model membranes; Nanomedicine for neglected diseases; Phospholipid monolayers

Indexed keywords

DERMASEPTIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLGLYCEROL;

ANTIMICROBIAL ACTIVITY; ARTICLE; BIOTECHNOLOGY; LEISHMANIA; MEMBRANE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMPHIBIAN PROTEINS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTIPROTOZOAL AGENTS; CELL MEMBRANE; LEISHMANIA; MEMBRANES, ARTIFICIAL; MODELS, BIOLOGICAL; PHOSPHOLIPIDS;

LEISHMANIA AMAZONENSIS;

EID: 80053194288     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1392     Document Type: Article

References (71)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
2. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999; 1462: 11-28.
3. Calderon LA, Silva-Jardim I, Zuliani JP, Silva AA, Ciancaglini P, Silva LHP, Stábeli RG. Amazonian biodiversity: a view of drug development for Leishmaniasis and Malaria. J. Braz. Chem. Soc. 2009; 20: 1011-1023.
4. Wang HZ, Chang CH, Lin CP, Tsai MC. J. Ocul. Pharmacol. Ther. 1996; 12: 35-43.
5. Blondelle SE, Lohner K, Aguilar MI. Lipid-induced conformation and lipid binding properties of cytolylic and antimicrobial peptides: determination and biological specificity. Biochim. Biophys. Acta 1999; 1462: 89-108.
6. Shai Y. Mechanism of binding, insertion and destabilization of phospholipids bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic. Biochim. Biophys. Acta 1999; 1462: 55-70.
7. Sitaram N, Nagaraj R. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim. Biophys. Acta 1999; 1462: 29-54.
8. Lohner K, Blondelle SE. Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics Comb. Chem. High Throughput Screen. 2005; 8: 241-256.
9. Jelinek R, Kolusheva S. Membrane interactions of host-defense peptides studied in model systems. Curr. Prot. Pep. Sci. 2005; 6: 103-114.
10. Salay LC, Qi W, Keshet B, Tamm LK, Fernandez EJ. Membrane interactions of a self-assembling model peptide that mimics the self-association, structure and toxicity of Abeta (1-40). Biochim. Biophys. Acta 2009; 1788: 1714-1721.
11. Tamm LK, McConnell HM. Supported phospholipids bilayers. Biophys. J. 1985; 47: 105-113.
12. Protopapa E, Aggeli A, Boden N, Knowles PF, Salay LC, Nelson A. Electrochemical screening of self-assembling β-sheet peptides using supported phospholipid monolayers. Med. Eng. Phys. 2006; 28: 944-955.
13. Santos LER, Colhone MC, Daghastanli KRP, Stabeli RG, Silva-Jardim I, Ciancaglini P. Lipid microspheres loaded with antigenic membrane proteins of the Leishmania amazonensis as a potential biotechnology application. J. Colloid Interface Sci. 2009; 340: 112-118.
14. Brand GD, Leite JRSA, Silva LP, Sá Mendel SM, Mesquita DA, Silva LP, Prates MV, Barbosa EB, Vinecky F, Martins GR, Galasso JH, Kuckelhaus SA, Sampaio RN, Furtado Jr JR, Andrade AC, Bloch Jr C. Novel dermaseptins from Phyllomedusa hypochondriallis (Amphibia). Biochem. Biophys. Res. Commun. 2006; 347: 739-746.
15. Leite JRSA, Brand GD, Silva LP, Kückelhaus SAS, Bento WRC, Araújo ALT, Martins GR, Lazzari AM, Bloch Jr, C. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: secondary structure, antimicrobial activity, and mammalian cell toxicity. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2008; 151: 336-343.
16. Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L. Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides. Virology 2004; 323: 268-275.
17. Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Bélec L, Haini K, Tangy F. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 2005; 334: 264-275.
18. Mor A, Hani K, Nicolas P. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 1994; 269: 31635-31641.
19. Brand GD, Leite JRSA, Silva LP, Albuquerque S, Prates MV, Azevedo RB, Carregaro V, Silva JS, Sá VCL, Brandão RA, Bloch Jr C. Dermaspetins from Phyllomedusa oreades and Phyllomedusa distincta: anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. J. Biol. Chem. 2002; 277: 49332-49340.
20. De Lucca AJ, Bland JM, Jacks TJ, Grimm C, Walsh TJ. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. Med. Mycol. 1998; 36: 291-298.
21. Efron L, Dagan A, Gaidukov L, Ginsburg H, Mor A. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 2002; 277: 24067-24072.
22. Brand GD, Krause FC, Silva LP, Leite JRSA, Melo JA, Prates MV, Pesquero JB, Santos EL, Nakaie CR, Costa-Neto CM, Bloch Jr C. Bradykinin-related peptides from Phyllomedusa hypochondrialis. Peptides 2006; 27: 2137-3146.
23. Jutila A, Söderlund T, Pakkanen AL, Huttunen M, Kinnunen PKJ. Comparison of the effects of clozapine, chlorpromazine, and haloperidol on membrane lateral heterogeneity. Chem. Phys. Lipids 2001; 112: 151-163.
24. Hidalgo AA, Caetano W, Tabak M, Oliveira Jr ON. Interaction of two phenothiazine derivatives with phospholipid monolayers. Biophys. Chem. 2004; 109: 85-104.
25. Souza SMB, Oliveira Jr ON, Scarpa MV, Oliveira AG. Study of the diclofenac/phospholipids interactions with liposomes and monolayers. Colloid Surf. B: Bionterfaces 2004; 36: 13-17.
26. Moraes ML, Bonardi C, Mendonça CR, Campana PT, Lottersberger J, Tonarelli G, Oliveira Jr ON, Beltramini LM. Cooperative effects in phospholipids monolayers induced by a peptide from HIV-1 capsid protein. Colloids Surf. B 2005; 41: 15-20.
27. Dynarowicz-œ1tka P, Dhanabalan A, Oliveira Jr ON. Modern physicochemical research on Langmuir monolayers. Adv. Colloid Interf. Sci. 2001; 91: 221-293.
28. Maget-Dana R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their intercations with lipid membranes. Biochim. Biophys. Acta 1999; 1462: 109-140.
29. Brockman H. Lipid monolayers: why use half a membrane to characterize protein-membrane interactions. Curr. Opin. Struct. Biol. 1999; 9: 438-443.
30. Volinsky R, Kolusheva S, Berman A, Jelinek R. Investigations of antimicrobial peptides in planar film systems. Biochim. Biophys. Acta 2006; 1758: 1393-1407.
31. Gidalevitz D, Ishitsuka Y, Muresan AS, Konovalov O, Waring AJ, Lehrer RI, Lee KY. Interaction of antimicrobial peptide protegrin with biomembranes. Proc. Natl. Acad. Sci. USA 2003; 100: 6302-6307.
32. Thakur G, Micic M, Leblanc RM. Surface chemistry of Alzheimer's disease: a Langmuir monolayer approach. Colloids Surf. B 2009; 74: 436-456.
33. Rosetti CM, Maggio B. Protein-induced surface structuring in myelin membrane monolayers. Biophys. J. 2007; 93: 4254-4267.
34. Volinsky R, Kolusheva S, Berman A, Jelinek R. Microscopic visualization of alamethicin incorporation into model membrane monolayers. Langmuir 2004; 20: 11084-11091.
35. Wagner K, Van Mau N, Boichot S, Kajava AV, Krauss U, Le Grimellec C, Beck-Sickinger A, Heitz F. Interactions of the human calcitonin fragment 9-32 with phospholipids: a monolayer study. Biophys. J. 2004; 87: 386-395.
36. Bouffioux O, Berquand A, Eeman M, Paquot M, Dufrêne YF, Brasseur R, Deleu M. Molecular organization of surfactin-phospholipid monolayers: effect of phospholipids chain length and polar head. Biochim. Biophys. Acta 2007; 1768: 1758-1768.
37. Lourenzoni MR, Namba AM, Caseli L, Degrève L, Zaniquelli MED. Study of the interaction of human defensins with cell membrane models: relationships between structure and biological activity. J.Phys. Chem. B 2007; 111: 11318-11329.
38. Batista CVF, da Silva LR, Sebben A, Scaloni A, Ferrara L, Paiva GR, Olamendi-Portugal T, Possani LD, Bloch C. Antimicrobial peptides from the Brazilian frog Phyllomedusa distincta. Peptides 1999; 20: 679-686.
39. Blume A. A comparative study of phase transitions of phospholipid bilayers and monolayers. Biochim. Biophys. Acta 1979; 557: 32-44.
40. Marsh D. Lateral pressure in membranes. Biochim. Biophys. Acta 1996; 1286: 183-223.
41. Caseli L, Masui DC, Furriel RPM, Leone FA, Zaniquelli MED. Adsorption kinetics and dilatational rheological studies for the soluble and anchored forms of alkaline phosphatase at the air/water interface. J. Braz. Chem. Soc. 2005; 16: 969-977.
42. Nobre TM, Wong WK, Zaniquelli MED. Equilibrium and dynamic aspects of dodecyltrimethylammonium bromide adsorption at the air/water interface in the presence of lambda-carrageenan. J. Colloid Interface Sci. 2007; 305: 142-149.
43. Borissevitch GP, Tabak M, Oliveira Jr fnmON. Interaction of dipyridamole with lipids in mixed Langmuir monolayers. Biochim. Biophys. Acta 1996; 1278: 12-18.
44. Davies JT, Rideal EK. Interfacial Phenomena. Academic Press: New York, 1963.
45. Romero EL, Morilla MJ. Drug delivery systems against leishmaniasis? Still an open question. Expert Opin. Drug. Delivery 2008; 5: 805-823.
46. Dwyer DM, Gottlieb M. The surface membrane chemistry of Leishmania: its possible role in parasite sequestration and survival. J. Cell. Biochem. 1983; 23: 35-45.
47. Rivas L, Luque-Ortega JR, Andreu D. Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim. Biophys. Acta 2009; 1788: 1570-1581.
48. Zhang K, Beverley SM. Phospholipid and sphingolipid metabolism in Leishmania. Mol. Biochem. Parasitol. 2010; 170: 55-64.
49. Beach DH, Holz Jr GG, Anekwe GE. Lipids of Leishmania promastigotes. J. Parasitol. 1979; 65: 201-216.
50. Wassef MK, Fioretti TB, Dwyer DM. Lipid analyses of isolated surface membranes of Leishmania donovani promastigotes. Lipids 1985; 20: 108-115.
51. Zufferey R, Allen S, Barron T, Sullivan DR, Denny PW, Almeida IC, Smith DF, Turco SJ, Ferguson MA, Beverley SM. Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J. Biol. Chem. 2003; 278: 44708-44718.
52. Zhang K, Hsu FF, Scott DA, Docampo R, Turk J, Beverley SM. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis. Mol. Microbiol. 2005; 55: 1566-1578.
53. Lorente SO, Rodrigues JCF, Jiménez CJ, Joyce-Menekse M, Rodrigues C, Croft SL, Yardley V, de Luca-Fradley K, Ruiz-Pérez LM, Urbina J, de Souza W, Pacanowska DG, Gilbert IH. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob. Agents Chemother. 2004; 48: 2937-2950.
54. Lopes JLS, Nobre TM, Siano A, Humpola V, Bossolan NRS, Zaniquelli MED, Tonarelli G, Beltramini LM. Disruption of Saccharomyces cerevisiae by Plantaricin 149 and investigation of its mechanisms of action with biomembrane model systems. Biochim. Biophys. Acta 2009; 1788: 2252-2258.
55. Silva LP, Leite JRSA, Brand GD, Regis WB, Tedesco AC, Azevedo RB, Freitas SM, Bloch Jr. CB. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta: liposomes fusion and/or lysis investigated by fluorescence and atomic force microscopy. Comp. Biochem. Physiol. A 2008; 151: 329-335.
56. Trommeshauser D, Krol S, Bergelson LD, Galla HJ. The effect of lipid composition and physical state of phospholipid monolayer on the binding and incorporation of a basic amphipathic peptide from the C-terminal region of the HIV envelope protein gp 41. Chem. Phys. Lipids 2000; 107: 83-92.
57. Maget-Dana R, Ptak M. Penetration of the insect defensin A into phospholipids monolayers and formation of defensin A-lipid complexes. Biophys. J. 1997; 73: 2527-2533.
58. Konovalov O, Myagkov I, Struth B, Lohner K. Lipid discrimination in phospholipid monolayers by the antimicrobial frog skin peptide PGLa. A synchrotron X-ray grazing incidence and reflectivity study. Eur. Biophys. J. 2002; 31: 428-437.
59. Zhao H, Mattila JP, Holopainen JM, Kinnunen PK. Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin. Biophys. J. 2001; 81: 2979-2991.
60. Bi X, Flach CR, Perez-Gil J, Plasencia I, Andreu D, Oliveira E, Mendelsohn R. Secondary structure and lipid interactions of the N-terminal segment of pulmonary surfactant SP-C in Langmuir films: IR reflection-absorption spectroscopy and surface pressure studies. Biochemistry 2002; 41: 8385-8395.
61. Demel RA, Peelen T, Slezen RJ, De Kruijff B, Kuipers OP. Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study. Eur. J. Biochem. 1996; 235: 267-274.
62. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 1992; 31: 12416-12423.
63. Duclohier H, Molle G, Spach G. Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers. Biophys. J. 1989; 56: 1017-1021.
64. Falla TJ, Karunaratne DN, Hancock REW. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 1996; 32: 19298-19303.
65. Salay LC, Procopio J, Oliveira E, Nakaie CR, Schreier S. Ion channel-like activity of the antimicrobial peptide tritrpticin in planar lipid bilayers. FEBS Lett. 2004; 565: 171-175.
66. Duclohier H. Bilayer lipid composition modulates the activity of dermaseptins, polycationic antimicrobial peptides. Eur. Biophys. J. 2006; 35: 401-409.
67. Andreu D, Rivas L. Animal antimicrobial peptides: an overview. Biopolymers 1998; 47: 415-433.
68. Brogden K. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria. Nature Rev. Microbiol. 2005; 3: 238-250.
69. Khandelia H, Ipsen JH, Mouritsen OG. The impact of peptides in lipid membranes. Biochim. Biophys. Acta 2008; 1778: 1528-1536.
70. Lohner K. In Development of Novel Antimicrobial Agents: Emerging Strategies. Lohner K (ed). Academic Press: Horizon Scientific, 2001; 149-165.
71. Lohner K, Prenner EJ. Differential scanning calorimetry and X-ray diffractions studies of the specificity of the interaction of the antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1999; 1462: 141-156.